• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中烟碱型和毒蕈碱型受体的成像:他克林治疗的效果

Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: effect of tacrine treatment.

作者信息

Nordberg A, Lundqvist H, Hartvig P, Andersson J, Johansson M, Hellstrŏm-Lindahi E, Långström B

机构信息

Department of Clinical Neuroscience and Family Medicine, Huddinge University Hospital, Sweden.

出版信息

Dement Geriatr Cogn Disord. 1997 Mar-Apr;8(2):78-84. doi: 10.1159/000106611.

DOI:10.1159/000106611
PMID:9065319
Abstract

Functional imaging techniques offer new possibilities for further understanding of changes in functional correlates of structural and biological changes in dementia disorders like Alzheimer's disease (AD). Regional disturbances in glucose metabolism and cerebral blood flow are known to occur in AD brains and probably roughly correlate to changes in neurotransmitter activities. A proper estimate would be to visualize the neuroreceptors themselves. In this study the cholinergic nicotinic and muscarinic receptors were studied in brain by positron emission tomography (PET). The rate constant k2* (s) (-)11C-nicotine was significantly higher (+43%) in temporal cortex of AD patients compared to controls (p < 0.017) indicating a lower binding of 11C-nicotine in AD brains compared to controls. Treatment with the cholinesterase inhibitor tacrine (80 mg daily) during 3 months to AD patients resulted in a mean plasma concentration of 7.7 +/- 0.8 ng/ml and a corresponding inhibition of the cholinesterase activity in plasma by 34 +/- 5%. A significantly lower k2* (increased binding) for 11C-nicotine binding (-15%; p < 0.006) was obtained in the temporal cortex after 3 months of treatment compared to prior treatment. The muscarinic antagonist 11C-benztropine was used to visualize muscarinic receptors and the binding capacity of 11C-benztropine (KR) was found to be decreased in the temporal cortex after 3 months of tacrine treatment.

摘要

功能成像技术为进一步理解痴呆症(如阿尔茨海默病,AD)中结构和生物学变化的功能关联变化提供了新的可能性。已知AD大脑中会出现葡萄糖代谢和脑血流量的局部紊乱,并且可能大致与神经递质活动的变化相关。更准确的评估是直接可视化神经受体本身。在本研究中,通过正电子发射断层扫描(PET)对大脑中的胆碱能烟碱受体和毒蕈碱受体进行了研究。与对照组相比,AD患者颞叶皮质中11C-尼古丁的速率常数k2*(s)(-)显著更高(+43%)(p < 0.017),这表明与对照组相比,AD大脑中11C-尼古丁的结合较低。给AD患者连续3个月每日服用胆碱酯酶抑制剂他克林(80毫克),导致平均血浆浓度为7.7 +/- 0.8纳克/毫升,血浆胆碱酯酶活性相应抑制34 +/- 5%。与治疗前相比,治疗3个月后颞叶皮质中11C-尼古丁结合的k2*显著降低(结合增加)(-15%;p < 0.006)。使用毒蕈碱拮抗剂11C-苯海索可视化毒蕈碱受体,发现他克林治疗3个月后颞叶皮质中11C-苯海索的结合能力(KR)降低。

相似文献

1
Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: effect of tacrine treatment.阿尔茨海默病中烟碱型和毒蕈碱型受体的成像:他克林治疗的效果
Dement Geriatr Cogn Disord. 1997 Mar-Apr;8(2):78-84. doi: 10.1159/000106611.
2
In vivo detection of neurotransmitter changes in Alzheimer's disease.阿尔茨海默病中神经递质变化的体内检测。
Ann N Y Acad Sci. 1993 Sep 24;695:27-33. doi: 10.1111/j.1749-6632.1993.tb23022.x.
3
Effect of long-term treatment with tacrine (THA) in Alzheimer's disease as visualized by PET.用正电子发射断层扫描(PET)观察他克林(THA)长期治疗对阿尔茨海默病的影响。
Acta Neurol Scand Suppl. 1993;149:62-5. doi: 10.1111/j.1600-0404.1993.tb04259.x.
4
Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography.通过正电子发射断层扫描可见,他克林可恢复阿尔茨海默病患者的胆碱能烟碱受体和葡萄糖代谢。
Neurobiol Aging. 1992 Nov-Dec;13(6):747-58. doi: 10.1016/0197-4580(92)90099-j.
5
PET studies and cholinergic therapy in Alzheimer's disease.阿尔茨海默病的正电子发射断层扫描(PET)研究与胆碱能治疗
Rev Neurol (Paris). 1999;155 Suppl 4:S53-63.
6
Cholinergic therapy in dementia.痴呆症中的胆碱能疗法。
Acta Neurol Scand Suppl. 1993;149:42-5. doi: 10.1111/j.1600-0404.1993.tb04254.x.
7
Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET.通过正电子发射断层扫描(PET)评估,轻度阿尔茨海默病患者接受卡巴拉汀治疗后脑内11C-尼古丁结合位点的变化。
Psychopharmacology (Berl). 2007 May;191(4):1005-14. doi: 10.1007/s00213-007-0725-z. Epub 2007 Feb 20.
8
Clinical studies in Alzheimer patients with positron emission tomography.阿尔茨海默病患者正电子发射断层扫描的临床研究。
Behav Brain Res. 1993 Nov 30;57(2):215-24. doi: 10.1016/0166-4328(93)90138-g.
9
Chronic treatments with tacrine and (-)-nicotine induce different changes of nicotinic and muscarinic acetylcholine receptors in the brain of aged rat.用他克林和(-)-尼古丁进行长期治疗会引起老年大鼠大脑中烟碱型和毒蕈碱型乙酰胆碱受体的不同变化。
J Neural Transm (Vienna). 2002 Mar;109(3):377-92. doi: 10.1007/s007020200030.
10
Long-term tacrine treatment in three mild Alzheimer patients: effects on nicotinic receptors, cerebral blood flow, glucose metabolism, EEG, and cognitive abilities.三名轻度阿尔茨海默病患者的长期他克林治疗:对烟碱受体、脑血流量、葡萄糖代谢、脑电图和认知能力的影响。
Alzheimer Dis Assoc Disord. 1998 Sep;12(3):228-37. doi: 10.1097/00002093-199809000-00017.

引用本文的文献

1
Neurotoxins Acting at Synaptic Sites: A Brief Review on Mechanisms and Clinical Applications.作用于突触部位的神经毒素:作用机制及临床应用简述
Toxins (Basel). 2022 Dec 27;15(1):18. doi: 10.3390/toxins15010018.
2
Cholinergic receptor binding in unimpaired older adults, mild cognitive impairment, and Alzheimer's disease dementia.未受损的老年成年人、轻度认知障碍和阿尔茨海默病痴呆患者的胆碱能受体结合。
Alzheimers Res Ther. 2022 Feb 7;14(1):25. doi: 10.1186/s13195-021-00954-w.
3
Therapeutic Targeting of 7 Nicotinic Acetylcholine Receptors.治疗性靶向 7 型烟碱型乙酰胆碱受体
Pharmacol Rev. 2021 Jul;73(3):1118-1149. doi: 10.1124/pharmrev.120.000097.
4
Nicotinic Acetylcholine Receptor α7 Subunit Is an Essential Regulator of Seizure Susceptibility.烟碱型乙酰胆碱受体α7亚基是癫痫易感性的重要调节因子。
Front Neurol. 2021 Apr 12;12:656752. doi: 10.3389/fneur.2021.656752. eCollection 2021.
5
Cholinergic Hypofunction in Presbycusis-Related Tinnitus With Cognitive Function Impairment: Emerging Hypotheses.与认知功能障碍相关的老年性聋伴耳鸣中的胆碱能功能减退:新出现的假说
Front Aging Neurosci. 2018 Apr 6;10:98. doi: 10.3389/fnagi.2018.00098. eCollection 2018.
6
Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT.阿尔茨海默病的药物研发:正电子发射断层扫描(PET)和单光子发射计算机断层扫描(SPECT)的贡献
Front Pharmacol. 2016 Mar 31;7:88. doi: 10.3389/fphar.2016.00088. eCollection 2016.
7
Cholinergic imaging in dementia spectrum disorders.痴呆谱系障碍中的胆碱能成像
Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1376-86. doi: 10.1007/s00259-016-3349-x. Epub 2016 Mar 16.
8
Brain imaging in the study of Alzheimer's disease.脑影像学在阿尔茨海默病研究中的应用。
Neuroimage. 2012 Jun;61(2):505-16. doi: 10.1016/j.neuroimage.2011.11.075. Epub 2011 Dec 7.
9
Brain imaging of nicotinic receptors in Alzheimer's disease.阿尔茨海默病中烟碱型受体的脑成像
Int J Alzheimers Dis. 2010 Dec 28;2010:548913. doi: 10.4061/2010/548913.
10
Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: an overview of preclinical and clinical findings.胆碱能受体亚型及其在认知、情绪和警觉控制中的作用:临床前和临床研究综述。
Psychopharmacology (Berl). 2011 May;215(2):205-29. doi: 10.1007/s00213-010-2153-8. Epub 2011 Jan 8.